Biotron initiates Phase IIa clinical trial in HCV patients
Biotron claims that BIT225 is a new drug with the potential to improve treatment options for HCV patients. The Phase IIa clinical trial is a combination study of
miRecule has signed a research collaboration with EM subsidiary Rio Biofarma Brasil (RBBL) to co-develop peptide-mediated delivery technologies aimed at improving targeted ribonucleic acid (RNA) therapeutics delivery to tissues beyond the liver and muscles in a range of disease areas.
Wellbutrin XL (bupropion hydrochloride) is an antidepressant of the aminoketone class and is chemically unrelated to tricyclic, tetracyclic, selective serotonin re-uptake inhibitor, or other known antidepressant agents. Wellbutrin